These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 20627670)

  • 1. [Alagille syndrome diagnosed in adolescence: a case report].
    Fadlouallah M; Krami H; Tamzaourte M; Lahmiri M; Tahri S; El Koundi H; Mahassini N; Jahid A; Errabih I; Ouazzani H
    Arch Pediatr; 2010 Jul; 17(7):1111-3. PubMed ID: 20627670
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of ursodeoxycholic acid in the treatment of arteriohepatic dysplasia.
    Kay MH; Wyllie R; Steffen RM
    Clin Pediatr (Phila); 1996 Nov; 35(11):593-6. PubMed ID: 8953135
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children.
    Lebensztejn DM
    Med Sci Monit; 2000; 6(3):632-6. PubMed ID: 11208384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alagille syndrome and Wilson disease in siblings: a diagnostic conundrum.
    Amson M; Lamoureux E; Hilzenrat N; Tischkowitz M
    Can J Gastroenterol; 2012 Jun; 26(6):330-2. PubMed ID: 22720273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural history of PBC: has it changed?
    Lee YM; Kaplan MM
    Semin Liver Dis; 2005 Aug; 25(3):321-6. PubMed ID: 16143947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E polymorphism in alagille syndrome and progressive familial intrahepatic cholestasis.
    Socha P; Nowicka G; Jankowska I; Rujner J; Pawłowska J; Socha J
    Dig Dis Sci; 2000 Apr; 45(4):675-9. PubMed ID: 10759233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term ursodeoxycholic acid treatment of cholestatic liver diseases in childhood--clinical and biochemical effects].
    Kardorff R; Melter M; Rodeck B; Brodehl J
    Klin Padiatr; 1996; 208(3):118-22. PubMed ID: 8676599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis.
    van de Nadort C; Houwen RH; Stapelbroek JM
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):490. PubMed ID: 18030221
    [No Abstract]   [Full Text] [Related]  

  • 9. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis.
    Lindor K
    N Engl J Med; 2007 Oct; 357(15):1524-9. PubMed ID: 17928600
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
    Stiefelhagen P
    MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
    [No Abstract]   [Full Text] [Related]  

  • 12. Ursodeoxycholic acid and long-term survival in primary biliary cirrhosis.
    Levy C; Angulo P
    Am J Gastroenterol; 2004 Feb; 99(2):269-70. PubMed ID: 15046216
    [No Abstract]   [Full Text] [Related]  

  • 13. Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis.
    Poupon R; Chrétien Y; Chazouillères O; Poupon RE
    J Hepatol; 2005 Mar; 42(3):418-9. PubMed ID: 15710226
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
    Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
    Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term beneficial effects of ursodeoxycholic acid in primary biliary cirrhosis are highly questionable.
    Yan G; Erik C; Gluud C
    Am J Gastroenterol; 2007 Feb; 102(2):464-5. PubMed ID: 17311669
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary biliary cirrhosis and CREST syndrome: a rare classical combination (literature review and case report)].
    Burnevich EZ; Ignatova TM
    Ter Arkh; 2000; 72(2):66-9. PubMed ID: 10717934
    [No Abstract]   [Full Text] [Related]  

  • 17. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
    Linares Rodríguez A
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
    [No Abstract]   [Full Text] [Related]  

  • 18. Pretransplant ursodeoxycholic acid therapy and liver transplantation in patients with primary biliary cirrhosis: win, win, win?
    Benner KG
    Liver Transpl Surg; 1999 Jul; 5(4):334-7. PubMed ID: 10388507
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary biliary cirrhosis.
    Gong Y; Christensen E; Gluud C
    N Engl J Med; 2005 Dec; 353(25):2719-20; author reply 2719-20. PubMed ID: 16379089
    [No Abstract]   [Full Text] [Related]  

  • 20. Eosinophils and primary biliary cirrhosis-stoking the fire?
    Neuberger J
    Hepatology; 1999 Jul; 30(1):335-7. PubMed ID: 10385676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.